Cate Speake, PhD, discusses research into the COVID-19 vaccine immune responses of people with autoimmune disease who use immunosuppressive drugs, or medications that slow down the immune system. Dr. Speake is a principal investigator in the Center for Interventional Immunology…
Our early phase clinical trials expert Pieter-Jan Berghmans, shares how our Clinical Pharmacology Unit teams in Antwerp are working hard to develop a safe and effective COVID-19 vaccine, aiding the global effort. #COVID19 #ClinicalTrials #Pharmacology #Vaccine #ClinicalResearch #ClinicalStudies #Pandemic
‘Generic Drug Repurposing for COVID-19” The Israeli Perspective’: Tel Aviv University’s Spark program recently hosted a webinar titled “Generic Drug Repurposing for COVID-19: The Israeli Perspective.” In collaboration with the MedInsight Institute, presenters included Professor Alex Jadad, Faculty of Medicine…
Dr. Negin Hajizadeh discussing Feinstein Institutes researchers finding an effective COVID-19 ‘cytokine storm’ treatment and more. Dr. Hajizadeh is an ICU pulmonologist and was a part of Northwell Health’s, NY largest health system, at the height of the surge. She…
COVID-19: Supporting the pandemic response webinar, showcases the work that has been taking place at the University of Southampton in response to the pandemic, using extensive expertise across many areas of research and medicine. For more information head to www.the-ciru.com…
Top Doctor at University of Hong Kong Suggests Aggressively Treat #COVID19 Patients Early with Antiviral Cocktail Medications: #HongKong’s medical community knows something about coronaviruses given its experience with the first SARS 17 years ago and of course the most recent…
